Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes

Blood Cells, Molecules, and Diseases

Volumn 27, Issue 3, 2001, Pages 559-571

  Magnani, Mauro ^a   Corsi, Dario ^a   Bianchi, Marzia ^a   Paiardini, Mirko ^a   Galluzzi, Luca ^a   Gargiullo, Elisa ^a   Parisi, Attilio ^b   Pigozzi, Fabio ^b  

^a UNIVERSITY OF URBINO   (Italy)

^b UNIVERSITY OF ROME FORO ITALICO   (Italy)

Author keywords

Doping; Erythroid markers; Erythropoietin; Ferritin; Soluble transferrin receptor

Indexed keywords

BETA GLOBIN; CYANOCOBALAMIN; FERRITIN; FOLIC ACID; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN RECEPTOR;

ADULT; AEROBIC METABOLISM; ARTICLE; ATHLETE; BLOOD EXAMINATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG USE; ERYTHROID CELL; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETICULOCYTE COUNT;

EID: 0034891227     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2001.0419     Document Type: Article

References (35)

1. Physiology of erythropoietin production
2. Erythropoietin
3. Proliferation of multipotent hematopoietic cells controlled by truncated erythropoietin receptor transgene
4. Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells
5. Erythropoietin receptor signals both proliferation and erythroid-specific differentiation
6. Human erythropoietin receptor: Cloning, expression, and biological characterization
7. Homodimerization and constitutive activation of the erythropoietin receptor
8. Biology of erythropoietin
9. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure
10. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin
11. Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5
12. Recombinant erythropoietin in urine
13. Clinical pharmacology of recombinant human erythropoietin (rHuEpo)
14. Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men
15. Development of a radioimmunoassay for human erythropoietin using recombinant erythropoietin as tracer and immunogen
16. Erythropoietin abuse in athletes
17. Population pharmacodynamics for monitoring epoetin in athletes
18. Structure, function and clinical significance of transferrin receptors
19. Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy
20. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen
21. Erythropoietin, iron metabolism and red blood cell production
22. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes
23. Molecular and population genetic analysis of allelic sequence diversity at the human β-globin locus
24. A method for quantification of absolute amounts of nucleic acids by (RT)-PCR and a new mathematical model for data analysis
25. Recombinant erythropoietin to improve athletic performance
26. Screening for exogenous erythropoietin
27. Laboratory screening for erythropoietin abuse in sport: An emerging challenge
28. Effects of erythropoietin administration in training athletes and possible indirect detection in doping control
29. Origin of a soluble truncated transferrin receptor
30. Circulating transferrin receptor assay - Coming of age
31. Recombinant human erythropoietin and the anemia of cancer
32. Erythropoietin and iron
33. Monitoring erythropoietin abuse in athletes